# Phase 1, Single and Multiple Doses Study of Sitaxentan in Japanese and Western Subjects

> **NCT00981968** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 22 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Sitaxentan sodium/Placebo
- **DRUG:** Sitaxentan sodium/Placebo

## Key facts

- **NCT ID:** NCT00981968
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2010-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00981968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00981968, "Phase 1, Single and Multiple Doses Study of Sitaxentan in Japanese and Western Subjects". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00981968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*